Jubilant Ingrevia's Financial Leap: A 17% Profit Surge
Jubilant Ingrevia Ltd reported a 17% rise in net profit for Q4 of FY26, amounting to Rs 86.44 crore. Total income rose to Rs 1,187.96 crore, up from Rs 1,059.62 crore in the previous year. The company's annual profit for FY26 grew to Rs 277.91 crore.
Jubilant Ingrevia Ltd, a prominent player in the speciality chemicals sector, has announced a 17% increase in its consolidated net profit for Q4 of the fiscal year ending March 2026. The company's profit reached Rs 86.44 crore, up from Rs 74 crore in the same period last year.
The total income for the quarter surged to Rs 1,187.96 crore, compared to Rs 1,059.62 crore in the previous year. This financial growth highlights the company's strong performance in serving diverse sectors including pharmaceuticals, nutrition, and semiconductors.
For the entire fiscal year FY26, Jubilant Ingrevia's net profit climbed to Rs 277.91 crore, with a total income of Rs 4,428.60 crore, marking a substantial increase from the prior fiscal year's figures. The company's expertise in speciality chemicals and contract development continues to drive its financial ascent.
(With inputs from agencies.)

